Compliance with Oral Anti-Diabetic Treatment in Lome
Compliance with Oral Anti-Diabetic Treatment in Lome作者机构:Internal Medicine Departement Université de Kara Kara Togo Internal Medicine Departement Université de Lomé Lomé Togo
出 版 物:《Open Journal of Internal Medicine》 (内科学期刊(英文))
年 卷 期:2024年第14卷第1期
页 面:53-63页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Type II Diabetes Metformin Compliance Associated Factors
摘 要:Objective: The objective of this study was to assess adherence to antidiabetic therapy in type II diabetic patients and factors associated with Lomé. Method: This was a descriptive observational study conducted among diabetics in diabetes care centers from May 1, 2020 to October 1, 2020, for a period of 6 months. Results: A total of 300 patients were questioned. The mean age was 56.61 years (standard deviation = 11.7). The sex ratio was 0.6. All the patients were on drug treatment, 83.4% of whom were on metformin and 37.5% on Glibenclamide. In 58.3% of the cases, the patients were on dual therapy and 96.2% had an abovenormal glycated hemoglobin value. There was a medication adherence problem with poor adherence in 30.7%. Being aged 50 and over (ORC = 1.78, p = 0.048), playing sports (ORR = 1.87, p = 0.046), have reaching a higher level of education (ORR = 5.78, p = 0.005) significantly increased the chances of patients having a good/minimal problem of adherence. Conclusion: Diabetes affects in Togo, more women than men with a predominance of those aged 50 and over. Adherence to therapy remains a challenge.